Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENCORAFENIB vs ENDOXAN INJ: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ENCORAFENIB vs ENDOXAN INJ: Safety Overview

Metric ENCORAFENIB ENDOXAN INJ
Total FAERS Reports 8,554 107
Deaths Reported 1,397 67
Death Rate 16.3% 62.6%
Hospitalizations 2,334 0
Average Patient Age 64.4 yrs 49.0 yrs
% Female Patients 50.9% N/A
FDA Approval Date Jun 27, 2018 N/A
Manufacturer Array BioPharma Inc. N/A
Route ORAL N/A
Marketing Status Discontinued N/A